GlassScriptPhysician profile
David M Roufaiel
NPI 1356669014
$57,962.54
in general payments reported to CMS, 2019-2025
35 companies · $2,507 in 2025
The $2,507 reported for 2025 was more than what 86% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,644 · 2020: $2,152 · 2021: $1,268 · 2022: $29K · 2023: $16K · 2024: $3,278 · 2025: $2,507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Food and Beverage: $3,710 · Education: $3,516 · Travel and Lodging: $1,428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,000.00 |
| Food and Beverage | $3,710.19 |
| Education | $3,516.04 |
| Travel and Lodging | $1,428.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $24,477.51 | 2021-2025 | Ha Minuteman G3-R |
| Vertos Medical, INC. | $14,220.32 | 2021-2024 | Mild Device Kit |
| Si-Bone, INC. | $4,047.18 | 2023-2024 | |
| Nevro Corp. | $2,620.88 | 2019-2024 | Senza |
| Nutech Spine, INC. | $2,500.00 | 2022 | |
| Boston Scientific Corporation | $2,165.56 | 2020-2025 | Intracept, Superion Indirect Decompression System, Wavewriter Alpha Prime 16 |
| Arthrex, INC. | $2,017.00 | 2019 | |
| Relievant Medsystems, INC. | $1,867.29 | 2020-2023 | Intracept |
| Abbott Laboratories | $719.42 | 2019-2025 | Proclaim, Eterna |
| Medtronic USA, INC. | $526.25 | 2019-2020 | |
| Medtronic, INC. | $520.70 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Abbvie INC. | $330.82 | 2023-2025 | Botox, Ubrelvy |
| Collegium Pharmaceutical, INC. | $314.64 | 2019-2024 | Belbuca, Xtampza |
| Scilex Pharmaceuticals INC. | $291.88 | 2019-2023 | Ztlido |
| Axonics, INC. | $241.65 | 2022-2024 | Axonics |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $236.18 | 2021-2025 | Nalu Neurostimulation System |
| Novo Nordisk INC | $146.11 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $122.89 | 2019-2024 | |
| Allergan, INC. | $73.80 | 2019-2021 | |
| Grt US Holding, INC. | $71.21 | 2022 | |
| Biodelivery Sciences International, INC. | $64.71 | 2019-2021 | |
| Stryker Corporation | $61.56 | 2025 | Ivas, Autoplex |
| Interventional Pain Technologies INC. | $47.97 | 2021 | |
| Globus Medical, INC. | $47.34 | 2025 | Senza |
| Spr Therapeutics, INC | $40.08 | 2025 | Sprint Pns System |
| Curonix LLC | $37.64 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stimwave Technologies Incorporated | $27.24 | 2021 | |
| Arbor Pharmaceuticals, INC. | $21.40 | 2019 | |
| Electronic Waveform Lab, INC. | $17.15 | 2019 | |
| Bioventus LLC | $14.98 | 2021 | |
| Depuy Synthes Sales INC. | $14.89 | 2021 | |
| Averitas Pharma INC. | $14.88 | 2023 | Qutenza |
| Biohaven Pharmaceuticals, INC. | $14.35 | 2021 | |
| Fidia Pharma USA INC. | $14.16 | 2025 | Hymhyn |
| Pacira Pharmaceuticals Incorporated | $12.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Roufaiel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.